In a model of non-ischemic HF in dogs (tachycardiomyopathy induced by pacemakers), IV infusion of GLP-1 increases left ventricular (LV) contractility (LV dP/dt increased by 98%, stroke volume by 102%, and cardiac output by 57%) and decreases LV end-diastolic pressure, heart rate, and systemic vascular resistance
Hydrogen sulfide signalling in neurodegenerative diseases
Symptoms present, workup pending: The patient presents with pain, tingling, or numbness attributable to diabetes
Instead of a quick note that disappears, GLP-1 medications (like semaglutide) are engineered to be long-lasting
They work alongside nutrition and physical activity
Common side effects include nausea, bloating, constipation, fatigue, and headaches